	The PROTAC milestone: FDA approval of vepdegestrant (ARV-471) for ESR1-mutated breast cancer. Drug Discov Today Lin X, Xiang H, Luo G. PMID: 42603649 [PubMed - as supplied by publisher]
	Preoperative stereotactic body radiotherapy for early-stage luminal breast cancer: a systematic review and meta-analysis (PRELUMEN). Radiother Oncol Viani GA, Arruda CV, Hamamura AC, Cardoso CE, Salmon HA, Amaral GO. PMID: 42603618 [PubMed - as supplied by publisher]
	Global prevalence of sexual dysfunction in women with ovarian cancer: a systematic review and meta-analysis. Cancer Treat Res Commun Salari N, Hesampour A, Hemmati M, Heidarian P, Mohammadi M. PMID: 42603545 [PubMed - as supplied by publisher]
	Sexual intimacy after breast cancer: A systematic review of qualitative studies on women's and partners' experiences in dating and romantic relationships. Body Image Rea H, Meyrick J, Lewis-Smith H. PMID: 42603448 [PubMed - as supplied by publisher]
	Hypoxia fuels JAK/STAT-LIV1 signaling: A promising therapeutic avenue in triple-negative breast cancer. Biomed Pharmacother Moorthi HM, V DR. PMID: 42603388 [PubMed - as supplied by publisher]
	CRYOTHERAPY FOR THE PREVENTION OF TAXANE-INDUCED PERIPHERAL NEUROPATHY IN BREAST CANCER: A PROSPECTIVE MULTICENTER STUDY. Georgian Med News Chikladze N, Kordzaia S, Svanadze L, Rukhadze T, Centeno C. PMID: 42603324 [PubMed - indexed for MEDLINE]
	A COMPARATIVE ANALYSIS OF TRENDS IN CERVICAL CANCER MORTALITY AMONG MESTIZO AND INDIGENOUS WOMEN IN ECUADOR, 2010-2024. Georgian Med News Pilco J, Cabezas C, Samaniego L, Sinchiguano G. PMID: 42603321 [PubMed - indexed for MEDLINE]
	Participation and Follow-Up Compliance in Cervical Cancer Screening According to Delivery Strategy for HPV Self-Collection: A Community Trial in Underserved Colombian Areas. Cancer Med Fernández-Deaza G, Ortíz N, Salazar A, Parra A, Morante-Caicedo C, Rodríguez M, Toca JD, Arria MA, Ceballos AK, Rodríguez J, Acosta D, Murillo R. PMID: 42603309 [PubMed - indexed for MEDLINE]
	Advances in quinazolin-4-one scaffolds in breast cancer therapy: emerging designs, mechanistic perspectives and SAR trends (2015-2025). RSC Med Chem Kaur S, Kasana S, Kurmi BD, Patel P. PMID: 42602855 [PubMed - as supplied by publisher]
	Methodological Concerns Regarding the Partially Randomized Design and Statistical Inference in Preoperative TEAS for Breast Cancer Patients: A Letter to the Editor [Letter]. J Pain Res Wei M. PMID: 42602658 [PubMed]
	Fertility-Sparing Management in Ovarian Cancer: A Systematic Review. Int J Womens Health Fitriyanto IA, Salima S, Iswanti W, Azizah JN. PMID: 42602654 [PubMed]
	In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. Biotechnol Notes Parab MM, Gupta PP, Shetty S, Chhajed SS, Shukla G, Bapat K, Dasgupta D, Boruah P. PMID: 42602599 [PubMed]
	A narrative review of in vitro studies on the role of reactive oxygen species in aggravating high-grade serous ovarian cancer development. Front Oncol Lee J, Yeo SG, Kim HO, Lee JM, Singh MK, Kim SS, Oh TI, Park DC. PMID: 42602565 [PubMed]
	Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making. Front Oncol Pelissier-Combescure M, Villemin JP, Bonzom D, Berger C, Estoup-Streiff C, Lakhman Y, Woitek R, Colombo PE, Lin Z, Li H, Nougaret S. PMID: 42602542 [PubMed]
	Impact of supportive bra use and surgical factors on seroma and pain following breast-conserving surgery: a single-center retrospective study. J Med Life Bölük SE, Bölük S, Bilgiç Ç, Ako. PMID: 42602434 [PubMed - indexed for MEDLINE]
	Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer. Ther Adv Med Oncol Cottu P, Pascual T, Lemonnier J, Hu H, Roux E, Connolly RM, Ma CX, Wolff AC, Crestani T, Tolosa P, Ferrero-Cafiero JM, Mulero-Sánchez A, Salvador F, Villacampa G, Gavilá J, de La Motte Rouge T, Prat A. PMID: 42602220 [PubMed]
	Dynamic circulating tumor DNA profiling of ESR1 mutations in HR+/HER2- advanced breast cancer: from prognostic biomarker to clinical decision-making - a comprehensive review. Front Oncol Ren S, Li P, Zhu D, Zhao L, Zhang X. PMID: 42601904 [PubMed]
	Longitudinal monitoring of circulating tumor cell phenotypic conversion as a predictor of late recurrence in breast cancer: a prospective feasibility study using the GenoCTC platform. Front Oncol Chelakkot C, Chelakkot VS, Shin H, Cho C, Park J, Choi J, Hong D, Lee HS, Shin YK. PMID: 42601892 [PubMed]
	Correlation study between inflammatory, nutritional and metabolic indicators and the risk of invasive ductal carcinoma of the breast. Front Oncol Chen P, Lv X, Su H, Wu H, Zhang Z, Zhang B, Zhang F. PMID: 42601855 [PubMed]
	Prognostic significance of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy: A retrospective cohort study. Medicine (Baltimore) Aliyev A, Adilli A, Ismayilsoy A, Aghayarli F, Babazade I, Ibrahimli A, Isayev C, Karn T, Gasimli B, Gasimli K. PMID: 42601757 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 333733

Page 1 of 16687



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy